INNOVATION FOR HEALTH

BUILD A GLOBAL AND INNOVATIVE BIOPHARMACEUTICAL ENTERPRISE

Production technology platform

Basic research and development platform

Planning to build Chongqing Regional Cell Preparation Center

ABOUT US
18000㎡

IND and NDA Platforms For Cell-based Drug

10+

Pipeline

5

Class I New Drugs

11

Indication

50

Patents

200+

R&D Elite

INTRODUCTION
CORPORATE
CULTURE
MANAGEMENT
TEAM
PIPELINE
READ MORE
R&D PLATFORM
READ MORE
CORE TECHNOLOGY
READ MORE
MANUFACTURING
READ MORE
NEWS & INFORMATION
2026-06-03
ASCO 2026: CEACAM5-Targeted CAR-T Therapy Achieves 57.1% Objective Response Rate Using One-Tenth of Conventional CAR-T Cell Doses
On June 2, 2026, Chongqing Precision Biotech presented Phase I clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting for its proprietary rapid-manufactured, IL-9–secreting CEACAM5-targeted CAR-T cell therapy administered via intraperitoneal infusion in patients with advanced colorectal cancer with peritoneal metastases (CRPM).
Learn More +
2026-05-15
Professor Qian Cheng Recognized Among the World’s Leading Scientists in the 2026 Global Scholar Academic Influence Ranking
The 2026 Global Scholar Academic Influence Ranking has been released,Professor Qian was ranked No. 71,558 worldwide, reflecting his contributions to scientific research and innovation in gene and cell therapy.
Learn More +
2026-04-24
Chongqing Precision Biotech Recognized for Innovation at BIONNOVA Forum；Prof. Qian Cheng Highlights Advances in In Vivo CAR-T
April 22–23, 2026 — Chongqing Precision Biotech Co., Ltd. was recognized with the “Most Innovative Pharmaceutical Company” award at the 7th BIONNOVA Biopharmaceutical Innovators Forum, held at Zha...
Learn More +
2026-03-04
Chongqing Precision Biotech Announces Nature Cancer Publication of Phase 1 Data for Hypoxia-Responsive CEA-Targeted CAR-T Therapy in Solid Tumors
February 27, 2026 — Chongqing Precision Biotech Co., Ltd. announced that results from a Phase 1 clinical study of its internally developed hypoxia-responsive CEA-targeted CAR-T cell therapy (PC13) ha...
Learn More +
READ MORE

FOLLOW US ON WECHAT

Building A, Gaoke Pioneer Park, Chuangye Avenue, Chongqing

+86(0)023-6817 7018

office@precision-biotech.com

© Copyright 2016-2025 重庆精准生物技术有限公司 All Rights Reserved

渝ICP备16003030号-1

渝公网安备 50010702505019号

 渝网药械信备字[2026]000022号 Design By:zhiing